RecruitingNot ApplicableNCT06799481

Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors

Virtually Delivered Home-Based Exercise Intervention on Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors: A Pilot Randomized Controlled Trial


Sponsor

Emory University

Enrollment

60 participants

Start Date

Feb 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the collection of microorganisms that exist in the intestines (gut microbiome). Up to 45% of AYA brain tumor survivors experience CRCI, including issues with attention and memory. CRCI can have a negative impact on education, independent living and can worsen long-term quality of life. Moderate-intensity levels of exercise, particularly aerobic and resistance training, have been shown to improve cognitive function. Additionally, exercise can change the composition and function of the gut microbiome, which may lead to improved cognitive function. Unfortunately, only about 50% of AYAs with cancer receive exercise information or meet the physical activity recommendations. Tailoring a virtually delivered exercise intervention to meet the unique needs of AYAs may improve access to exercise. Participating in the virtual home-based exercise intervention, RISE, may improve physical activity and cognitive impairment in AYA brain tumor survivors and may also help researchers understand the relationship of exercise on the gut microbiome and cognitive function.


Eligibility

Min Age: 15 YearsMax Age: 39 Years

Inclusion Criteria8

  • Age 15-39 years
  • With primary brain tumor with cranial radiotherapy
  • months to 4 years post cranial radiotherapy
  • Functional Assessment of Cancer Therapy (FACT)-Cognitive Function score \< 60 based on self-report (used among AYAs with non-neural cancer)
  • Able to provide informed consent/assent
  • Able to walk and receive clearance from a provider to participate based on the Physical Activity Readiness Questionnaire
  • Currently engaging in \< 150 minutes of physical activity per week
  • Willing to use smartphone-based applications (app)

Exclusion Criteria3

  • Secondary malignancies, germline genetic syndrome, or recurrent disease requiring re-irradiation of the brain
  • Moderate to severe traumatic brain injury with brain damage beyond that expected from brain tumor and treatment
  • Developmental disorders (e.g., autism) or major psychotic illness (e.g., schizophrenia, depression) to avoid confounding impact related to these disorders

Interventions

OTHERAerobic Exercise

Participate in personalized, progressive aerobic training

BEHAVIORALBehavioral Intervention

Receive active lifestyle behavior coaching

PROCEDUREFollow-Up

Receive calls from the trainer

OTHERInternet-Based Intervention

Receive access to Physitrack

OTHERMedical Device Usage and Evaluation

Wear a Fitbit monitor

OTHERQuestionnaire Administration

Ancillary studies

OTHERResistance Training

Participating in strength training exercises


Locations(2)

Emory University Hospital

Atlanta, Georgia, United States

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06799481


Related Trials